Junctional Epidermolysis Bullosa, Generalized Intermediate
Description
Generalized non-Herlitz-type junctional epidermolysis bullosa is a form of non-Herlitz-type junctional epidermolysis bullosa (JEB-nH, see this term) characterized by generalized skin blistering, atrophic scarring, nail dystrophy or nail absence, and enamel hypoplasia, with extracutaneous involvement.
Genes related to Junctional Epidermolysis Bullosa, Generalized Intermediate
- ITGB4
- COL17A1
- LAMB3
- LAMC2
- LAMA3
Clinical Features
Top most frequent phenotypes and symptoms related to Junctional Epidermolysis Bullosa, Generalized Intermediate
- Growth delay
- Anemia
- Nail dystrophy
- Abnormality of skin pigmentation
- Palmoplantar keratoderma
- Abnormal blistering of the skin
- Hypoplasia of dental enamel
- Anonychia
- Milia
- Atrophic scars
And another 4 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Junctional Epidermolysis Bullosa, Generalized Intermediate Is also known as junctional epidermolysis bullosa, disentis type, generalized junctional epidermolysis bullosa, non-herlitz type, gabeb, jeb-nh gen, jeb, generalized intermediate, generalized atrophic benign epidermolysis bullosa, junctional epidermolysis bullosa generalisata m.
Researches and researchers
Doctors, researchs, and experts related to Junctional Epidermolysis Bullosa, Generalized Intermediate extracted from public data.
Junctional Epidermolysis Bullosa, Generalized Intermediate Experts map
Current Researchs and researchers
-
SALZBURG — Pr Johann BAUER
Clinical expert - Responsible for diagnostic tests - Principal investigator of clinical trial - Investigator of research project - Sponsor of orphan designation - Director of laboratory - Director of department
-
Institution/s:
— Universitätsklinik für Dermatologie, Salzburger Landeskliniken (SALK) / Paracelsus Med. Privatuniversität (PMU)
— Salzburger Landeskliniken (SALK) / Paracelsus Med. Privatuniversität (PMU)
— Salzburger Landeskliniken (SALK) / Paracelsus Med. Privatuniversität (PMU) -
Research area/topic::
Development of small molecule therapy in Epidermolysis bullosa
-
Institution/s:
Junctional Epidermolysis Bullosa, Generalized Intermediate Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
EBSeq Epidermolysis Bullosa Panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
DST, TGM5, FERMT1, CHST8, CD151, CDSN, COL17A1, COL7A1, KLHL24, DSP, EXPH5, ITGA3, ITGA6, ITGB4, JUP, KRT14, KRT5, LAMA3, LAMB3, LAMC2 , (...)
View the complete list with 2 more genes
Specificity
23 %
Genes
100 % |
ITGB4 Gene Sequencing.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
ITGB4
Specificity
100 %
Genes
20 % |
ITGB4 Deletion/duplication analysis.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
ITGB4
Specificity
100 %
Genes
20 % |
EB (Epidermolysis Bullosa) Deletion/Duplication panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
DST, TGM5, FERMT1, CHST8, CD151, CDSN, COL17A1, COL7A1, DSP, EXPH5, ITGA3, ITGA6, ITGB4, JUP, KRT5, LAMA3, LAMB3, LAMC2, PKP1, PLEC
Specificity
25 %
Genes
100 % |
ITGB4.
By Institute for Human Genetics University Clinic Freiburg (Germany).
ITGB4
Specificity
100 %
Genes
20 % |
Exome PLUS Proteinuria/FSGS & Hematuria.
By Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine (United States).
CFB, TRPC6, TSC1, TSC2, C1QA, C1QC, WT1, C3, NPHS2, ADAMTS13, ACTN4, PLCE1, CLCN5, COL4A3, COL4A4, COL4A5, INF2, DGKE, ALMS1, GLA , (...)
View the complete list with 12 more genes
Specificity
4 %
Genes
20 % |
ITGB4. NextGeneDx.Complete sequencing by NGS.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ITGB4
Specificity
100 %
Genes
20 % |
ITGB4. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
ITGB4
Specificity
100 %
Genes
20 % |
You can get up to 107 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A PROGEROID SYNDROME, PETTY TYPE CHITAYAT SYNDROME; CHYTS